HIV infection in intravenous drug users entering drug treatment, United States, 1988 to 1989. The Field Services Branch of the Centers for Disease Control.
Author(s) -
David M. Allen,
Ida M. Onorato,
T A Green
Publication year - 1992
Publication title -
american journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.284
H-Index - 264
eISSN - 1541-0048
pISSN - 0090-0036
DOI - 10.2105/ajph.82.4.541
Subject(s) - seroprevalence , medicine , transmission (telecommunications) , intravenous drug , public health , demography , environmental health , expanded access , drug injection , human immunodeficiency virus (hiv) , disease control , viral disease , virology , immunology , antibody , serology , sociology , electrical engineering , engineering , nursing
Intravenous drug use has played a key role in the human immunodeficiency virus (HIV) epidemic. Standardized surveillance of HIV infection among intravenous drug users (IVDUs) is needed to determine HIV prevalence rates, to monitor changes in prevalence over time, and to describe behaviors associated with HIV infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom